A new guidance by the FDA lifts the deferral for donating blood for those who were previously deferred due to spending time or living in the United Kingdom, France or Ireland. The FDA determined there is no longer a risk of transmitting Cruetzfeldt-Jakob Disease (or mad cow disease) to patients receiving blood transfusions.
